Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Nov;81(6):1071–1079. doi: 10.1038/sj.bjc.6690809

Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma

H Kosmehl 1, A Berndt 1, S Strassburger 2, L Borsi 3, P Rousselle 4, U Mandel 5, P Hyckel 2, L Zardi 3, D Katenkamp 1
PMCID: PMC2362955  PMID: 10576667

Abstract

The expression of laminin and fibronectin isoforms varies with cellular maturation and differentiation and these differences may well influence cellular processes such as adhesion and motility. The basement membrane (BM) of fetal oral squamous epithelium contains the laminin chains, α2, α3, α5, β1, β2, β3, γ1 and γ2. The BM of adult normal oral squamous epithelium comprises the laminin chains, α3, α5, β1, β3, γ1 and γ2. A re-expression of the laminin α2 and β2 chains could be shown in adult hyperproliferative, dysplastic and carcinomatous lesions. In dysplasia and oral squamous cell carcinoma (OSCC), multifocal breaks of the BM are present as indicated by laminin chain antibodies. These breaks correlate to malignancy grade in their extent. Moreover, in the invasion front the α3 and γ2 chain of laminin-5 can immunohistochemically be found outside the BM within the cytoplasm of budding carcinoma cells and in the adjacent stroma. The correlation between the morphological pattern of invasive tumour clusters and a laminin-5 immunostaining in the adjacent stroma may suggest, first, that a laminin-5 deposition outside the BM is an immunohistochemical marker for invasion and second, that OSCC invasion is guided by the laminin-5 matrix. Expression of oncofetal fibronectins (IIICS de novo glycosylated fibronectin and ED-B fibronectin) could be demonstrated throughout the stromal compartment. However, the ED-B fibronectin synthesizing cells (RNA/RNA in situ hybridization) are confined to small stroma areas and to single stroma and inflammatory cells in the invasion front. A correlation of the number of ED-B fibronectin synthesizing cells to malignancy grade could not be seen. ED-B fibronectin mRNA-positive cells seem to be concentrated in areas of fibrous stroma recruitment with a linear alignment of stromal fibro-/myofibroblasts (desmoplasia). Double staining experiments (ED-B fibronectin in situ hybridization and α-smooth muscle actin immunohistochemistry) indicated that the stroma myofibroblasts are a preferential source of ED-B fibronectin. In conclusion, in OSCC, a fetal extracellular matrix conversion is demonstrable. Tumour cells (laminin α2 and β2 chain) and recruited stromal myofibroblasts (oncofetal ED-B fibronectin) contribute to the fetal extracellular matrix milieu. © 1999 Cancer Research Campaign

Keywords: oral squamous cell carcinoma, laminin isoforms, fibronectin isoforms, ED-B fibronectin in situ hybridization, myofibroblasts, oncofetal extracellular matrix

Full Text

The Full Text of this article is available as a PDF (737.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes J. L., Torres E. S., Mitchell R. J., Peters J. H. Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis. Am J Pathol. 1995 Nov;147(5):1361–1371. [PMC free article] [PubMed] [Google Scholar]
  2. Berndt A., Hyckel P., Könneker A., Katenkamp D., Kosmehl H. Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation. clues from an in vitro invasion model. Invasion Metastasis. 1997;17(5):251–258. [PubMed] [Google Scholar]
  3. Berndt A., Kosmehl H., Mandel U., Gabler U., Luo X., Celeda D., Zardi L., Katenkamp D. TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J. 1995 Dec;27(12):1014–1020. [PubMed] [Google Scholar]
  4. Borsi L., Carnemolla B., Castellani P., Rosellini C., Vecchio D., Allemanni G., Chang S. E., Taylor-Papadimitriou J., Pande H., Zardi L. Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol. 1987 Mar;104(3):595–600. doi: 10.1083/jcb.104.3.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Borsi L., Castellani P., Risso A. M., Leprini A., Zardi L. Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett. 1990 Feb 12;261(1):175–178. doi: 10.1016/0014-5793(90)80664-5. [DOI] [PubMed] [Google Scholar]
  6. Brouty-Boyé D., Magnien V. Myofibroblast and concurrent ED-B fibronectin phenotype in human stromal cells cultured from non-malignant and malignant breast tissue. Eur J Cancer. 1994;30A(1):66–73. doi: 10.1016/s0959-8049(05)80021-8. [DOI] [PubMed] [Google Scholar]
  7. Bryne M., Koppang H. S., Lilleng R., Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992 Apr;166(4):375–381. doi: 10.1002/path.1711660409. [DOI] [PubMed] [Google Scholar]
  8. Burton-Wurster N., Lust G., Macleod J. N. Cartilage fibronectin isoforms: in search of functions for a special population of matrix glycoproteins. Matrix Biol. 1997 Mar;15(7):441–454. doi: 10.1016/s0945-053x(97)90018-4. [DOI] [PubMed] [Google Scholar]
  9. Carnemolla B., Balza E., Siri A., Zardi L., Nicotra M. R., Bigotti A., Natali P. G. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol. 1989 Mar;108(3):1139–1148. doi: 10.1083/jcb.108.3.1139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Carnemolla B., Neri D., Castellani P., Leprini A., Neri G., Pini A., Winter G., Zardi L. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int J Cancer. 1996 Nov 4;68(3):397–405. doi: 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  11. Castellani P., Viale G., Dorcaratto A., Nicolo G., Kaczmarek J., Querze G., Zardi L. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer. 1994 Dec 1;59(5):612–618. doi: 10.1002/ijc.2910590507. [DOI] [PubMed] [Google Scholar]
  12. Chen W., Culp L. A. Adhesion mediated by fibronectin's alternatively spliced EDb (EIIIB) and its neighboring type III repeats. Exp Cell Res. 1996 Feb 25;223(1):9–19. doi: 10.1006/excr.1996.0053. [DOI] [PubMed] [Google Scholar]
  13. Downer C. S., Watt F. M., Speight P. M. Loss of alpha 6 and beta 4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol. 1993 Nov;171(3):183–190. doi: 10.1002/path.1711710306. [DOI] [PubMed] [Google Scholar]
  14. Durkin M. E., Loechel F., Mattei M. G., Gilpin B. J., Albrechtsen R., Wewer U. M. Tissue-specific expression of the human laminin alpha5-chain, and mapping of the gene to human chromosome 20q13.2-13.3 and to distal mouse chromosome 2 near the locus for the ragged (Ra) mutation. FEBS Lett. 1997 Jul 14;411(2-3):296–300. doi: 10.1016/s0014-5793(97)00686-8. [DOI] [PubMed] [Google Scholar]
  15. Ekblom M., Klein G., Mugrauer G., Fecker L., Deutzmann R., Timpl R., Ekblom P. Transient and locally restricted expression of laminin A chain mRNA by developing epithelial cells during kidney organogenesis. Cell. 1990 Jan 26;60(2):337–346. doi: 10.1016/0092-8674(90)90748-4. [DOI] [PubMed] [Google Scholar]
  16. Engvall E., Earwicker D., Haaparanta T., Ruoslahti E., Sanes J. R. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul. 1990 Sep;1(10):731–740. doi: 10.1091/mbc.1.10.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harada T., Shinohara M., Nakamura S., Oka M. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch. 1994;424(3):257–266. doi: 10.1007/BF00194609. [DOI] [PubMed] [Google Scholar]
  18. Hashimoto-Uoshima M., Yan Y. Z., Schneider G., Aukhil I. The alternatively spliced domains EIIIB and EIIIA of human fibronectin affect cell adhesion and spreading. J Cell Sci. 1997 Sep;110(Pt 18):2271–2280. doi: 10.1242/jcs.110.18.2271. [DOI] [PubMed] [Google Scholar]
  19. Hori H., Kanamori T., Mizuta T., Yamaguchi N., Liu Y., Nagai Y. Human laminin M chain: epitope analysis of its monoclonal antibodies by immunoscreening of cDNA clones and tissue expression. J Biochem. 1994 Dec;116(6):1212–1219. doi: 10.1093/oxfordjournals.jbchem.a124666. [DOI] [PubMed] [Google Scholar]
  20. Hruban R. H., Kuhajda F. P., Mann R. B. Acute myelofibrosis. Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia. Am J Clin Pathol. 1987 Nov;88(5):578–588. doi: 10.1093/ajcp/88.5.578. [DOI] [PubMed] [Google Scholar]
  21. Hsi B. L., Yeh C. J. Monoclonal antibodies to human amnion. J Reprod Immunol. 1986 Apr;9(1):11–21. doi: 10.1016/0165-0378(86)90021-5. [DOI] [PubMed] [Google Scholar]
  22. Iivanainen A., Vuolteenaho R., Sainio K., Eddy R., Shows T. B., Sariola H., Tryggvason K. The human laminin beta 2 chain (S-laminin): structure, expression in fetal tissues and chromosomal assignment of the LAMB2 gene. Matrix Biol. 1995 Feb;14(6):489–497. doi: 10.1016/0945-053x(95)90006-3. [DOI] [PubMed] [Google Scholar]
  23. Kaczmarek J., Castellani P., Nicolo G., Spina B., Allemanni G., Zardi L. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer. 1994 Oct 1;59(1):11–16. doi: 10.1002/ijc.2910590104. [DOI] [PubMed] [Google Scholar]
  24. Kainulainen T., Autio-Harmainen H., Oikarinen A., Salo S., Tryggvason K., Salo T. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol. 1997 Mar;136(3):331–336. [PubMed] [Google Scholar]
  25. Kikkawa Y., Sanzen N., Sekiguchi K. Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. laminin-10/11 mediates cell adhesion through integrin alpha3 beta1. J Biol Chem. 1998 Jun 19;273(25):15854–15859. doi: 10.1074/jbc.273.25.15854. [DOI] [PubMed] [Google Scholar]
  26. Klein G., Ekblom M., Fecker L., Timpl R., Ekblom P. Differential expression of laminin A and B chains during development of embryonic mouse organs. Development. 1990 Nov;110(3):823–837. doi: 10.1242/dev.110.3.823. [DOI] [PubMed] [Google Scholar]
  27. Kobayashi Y., Nakajima T., Saku T. Loss of basement membranes in the invading front of O-1N, hamster squamous cell carcinoma with high potential of lymph node metastasis: an immunohistochemical study for laminin and type IV collagen. Pathol Int. 1995 May;45(5):327–334. doi: 10.1111/j.1440-1827.1995.tb03465.x. [DOI] [PubMed] [Google Scholar]
  28. Korang K., Christiano A. M., Uitto J., Mauviel A. Differential cytokine modulation of the genes LAMA3, LAMB3, and LAMC2, encoding the constitutive polypeptides, alpha 3, beta 3, and gamma 2, of human laminin 5 in epidermal keratinocytes. FEBS Lett. 1995 Jul 24;368(3):556–558. doi: 10.1016/0014-5793(95)00740-z. [DOI] [PubMed] [Google Scholar]
  29. Kornblihtt A. R., Pesce C. G., Alonso C. R., Cramer P., Srebrow A., Werbajh S., Muro A. F. The fibronectin gene as a model for splicing and transcription studies. FASEB J. 1996 Feb;10(2):248–257. doi: 10.1096/fasebj.10.2.8641558. [DOI] [PubMed] [Google Scholar]
  30. Kosmehl H., Berndt A., Katenkamp D., Hyckel P., Stiller K. J., Gabler U., Langbein L., Reh T. Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. A quantitative immunohistochemical study. J Oral Pathol Med. 1995 Sep;24(8):343–348. doi: 10.1111/j.1600-0714.1995.tb01197.x. [DOI] [PubMed] [Google Scholar]
  31. Kosmehl H., Berndt A., Katenkamp D., Mandel U., Bohle R., Gabler U., Celeda D. Differential expression of fibronectin splice variants, oncofetal glycosylated fibronectin and laminin isoforms in nodular palmar fibromatosis. Pathol Res Pract. 1995 Nov;191(11):1105–1113. doi: 10.1016/S0344-0338(11)80655-2. [DOI] [PubMed] [Google Scholar]
  32. Kosmehl H., Berndt A., Katenkamp D. Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch. 1996 Dec;429(6):311–322. doi: 10.1007/BF00198435. [DOI] [PubMed] [Google Scholar]
  33. Leivo I., Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1544–1548. doi: 10.1073/pnas.85.5.1544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Loridon-Rosa B., Vielh P., Matsuura H., Clausen H., Cuadrado C., Burtin P. Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections. Cancer Res. 1990 Mar 1;50(5):1608–1612. [PubMed] [Google Scholar]
  35. Mandel U., Gaggero B., Reibel J., Therkildsen M. H., Dabelsteen E., Clausen H. Oncofetal fibronectins in oral carcinomas: correlation of two different types. APMIS. 1994 Sep;102(9):695–702. [PubMed] [Google Scholar]
  36. Mandel U., Hamilton Therkildsen M., Reibel J., Sweeney B., Matsuura H., Hakomori S., Dabelsteen E., Clausen H. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies. APMIS. 1992 Sep;100(9):817–826. [PubMed] [Google Scholar]
  37. Marinkovich M. P., Lunstrum G. P., Keene D. R., Burgeson R. E. The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol. 1992 Nov;119(3):695–703. doi: 10.1083/jcb.119.3.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Matsuura H., Hakomori S. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6517–6521. doi: 10.1073/pnas.82.19.6517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Miner J. H., Patton B. L., Lentz S. I., Gilbert D. J., Snider W. D., Jenkins N. A., Copeland N. G., Sanes J. R. The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J Cell Biol. 1997 May 5;137(3):685–701. doi: 10.1083/jcb.137.3.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Miner J. H., Sanes J. R. Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J Cell Biol. 1994 Nov;127(3):879–891. doi: 10.1083/jcb.127.3.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nickeleit V., Zagachin L., Nishikawa K., Peters J. H., Hynes R. O., Colvin R. B. Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis. Am J Pathol. 1995 Oct;147(4):965–978. [PMC free article] [PubMed] [Google Scholar]
  42. O'Toole E. A., Marinkovich M. P., Hoeffler W. K., Furthmayr H., Woodley D. T. Laminin-5 inhibits human keratinocyte migration. Exp Cell Res. 1997 Jun 15;233(2):330–339. doi: 10.1006/excr.1997.3586. [DOI] [PubMed] [Google Scholar]
  43. Odermatt B. F., Lang A. B., Rüttner J. R., Winterhalter K. H., Trüeb B. Monoclonal antibodies to human type IV collagen: useful reagents to demonstrate the heterotrimeric nature of the molecule. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7343–7347. doi: 10.1073/pnas.81.23.7343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pujuguet P., Hammann A., Moutet M., Samuel J. L., Martin F., Martin M. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol. 1996 Feb;148(2):579–592. [PMC free article] [PubMed] [Google Scholar]
  45. Pyke C., Rømer J., Kallunki P., Lund L. R., Ralfkiaer E., Danø K., Tryggvason K. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol. 1994 Oct;145(4):782–791. [PMC free article] [PubMed] [Google Scholar]
  46. Rousselle P., Golbik R., van der Rest M., Aumailley M. Structural requirement for cell adhesion to kalinin (laminin-5). J Biol Chem. 1995 Jun 9;270(23):13766–13770. doi: 10.1074/jbc.270.23.13766. [DOI] [PubMed] [Google Scholar]
  47. Rousselle P., Lunstrum G. P., Keene D. R., Burgeson R. E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol. 1991 Aug;114(3):567–576. doi: 10.1083/jcb.114.3.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ryan M. C., Christiano A. M., Engvall E., Wewer U. M., Miner J. H., Sanes J. R., Burgeson R. E. The functions of laminins: lessons from in vivo studies. Matrix Biol. 1996 Dec;15(6):369–381. doi: 10.1016/s0945-053x(96)90157-2. [DOI] [PubMed] [Google Scholar]
  49. Sanes J. R., Chiu A. Y. The basal lamina of the neuromuscular junction. Cold Spring Harb Symp Quant Biol. 1983;48(Pt 2):667–678. doi: 10.1101/sqb.1983.048.01.070. [DOI] [PubMed] [Google Scholar]
  50. Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D., Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986 Dec;103(6 Pt 2):2787–2796. doi: 10.1083/jcb.103.6.2787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sollberg S., Peltonen J., Uitto J. Differential expression of laminin isoforms and beta 4 integrin epitopes in the basement membrane zone of normal human skin and basal cell carcinomas. J Invest Dermatol. 1992 Jun;98(6):864–870. doi: 10.1111/1523-1747.ep12457080. [DOI] [PubMed] [Google Scholar]
  52. Sordat I., Bosman F. T., Dorta G., Rousselle P., Aberdam D., Blum A. L., Sordat B. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol. 1998 May;185(1):44–52. doi: 10.1002/(SICI)1096-9896(199805)185:1<44::AID-PATH46>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  53. Squarzoni S., Villanova M., Sabatelli P., Malandrini A., Toti P., Pini A., Merlini L., Guazzi G. C., Maraldi N. M. Intracellular detection of laminin alpha 2 chain in skin by electron microscopy immunocytochemistry: comparison between normal and laminin alpha 2 chain deficient subjects. Neuromuscul Disord. 1997 Mar;7(2):91–98. doi: 10.1016/s0960-8966(96)00420-8. [DOI] [PubMed] [Google Scholar]
  54. Strassburger S., Berndt A., Hyckel P., Katenkamp D., Kosmehl H. Differential expression of laminin chains in the human major salivary gland. Histochem J. 1998 Feb;30(2):81–88. doi: 10.1023/a:1003226931910. [DOI] [PubMed] [Google Scholar]
  55. Tani T., Lumme A., Linnala A., Kivilaakso E., Kiviluoto T., Burgeson R. E., Kangas L., Leivo I., Virtanen I. Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am J Pathol. 1997 Nov;151(5):1289–1302. [PMC free article] [PubMed] [Google Scholar]
  56. Thorup A. K., Dabelsteen E., Schou S., Gil S. G., Carter W. G., Reibel J. Differential expression of integrins and laminin-5 in normal oral epithelia. APMIS. 1997 Jul;105(7):519–530. doi: 10.1111/j.1699-0463.1997.tb05049.x. [DOI] [PubMed] [Google Scholar]
  57. Tiger C. F., Champliaud M. F., Pedrosa-Domellof F., Thornell L. E., Ekblom P., Gullberg D. Presence of laminin alpha5 chain and lack of laminin alpha1 chain during human muscle development and in muscular dystrophies. J Biol Chem. 1997 Nov 7;272(45):28590–28595. doi: 10.1074/jbc.272.45.28590. [DOI] [PubMed] [Google Scholar]
  58. Uriel J. Retrodifferentiation and the fetal patterns of gene expression in cancer. Adv Cancer Res. 1979;29:127–174. doi: 10.1016/s0065-230x(08)60847-7. [DOI] [PubMed] [Google Scholar]
  59. Wayner E. A., Gil S. G., Murphy G. F., Wilke M. S., Carter W. G. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol. 1993 Jun;121(5):1141–1152. doi: 10.1083/jcb.121.5.1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wewer U. M., Wayner E. A., Hoffstrom B. G., Lan F., Meyer-Nielsen B., Engvall E., Albrechtsen R. Selective assembly of laminin variants by human carcinoma cells. Lab Invest. 1994 Nov;71(5):719–730. [PubMed] [Google Scholar]
  61. Wewer U., Albrechtsen R., Manthorpe M., Varon S., Engvall E., Ruoslahti E. Human laminin isolated in a nearly intact, biologically active form from placenta by limited proteolysis. J Biol Chem. 1983 Oct 25;258(20):12654–12660. [PubMed] [Google Scholar]
  62. Williamson R. A., Henry M. D., Daniels K. J., Hrstka R. F., Lee J. C., Sunada Y., Ibraghimov-Beskrovnaya O., Campbell K. P. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet. 1997 Jun;6(6):831–841. doi: 10.1093/hmg/6.6.831. [DOI] [PubMed] [Google Scholar]
  63. Xia P., Culp L. A. Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA): complementarity to plasma fibronectin functions. Exp Cell Res. 1995 Apr;217(2):517–527. doi: 10.1006/excr.1995.1117. [DOI] [PubMed] [Google Scholar]
  64. Zardi L., Carnemolla B., Siri A., Santi L., Accolla R. S. Somatic cell hybrids producing antibodies specific to human fibronectin. Int J Cancer. 1980 Mar 15;25(3):325–329. doi: 10.1002/ijc.2910250304. [DOI] [PubMed] [Google Scholar]
  65. Zhang K., Kramer R. H. Laminin 5 deposition promotes keratinocyte motility. Exp Cell Res. 1996 Sep 15;227(2):309–322. doi: 10.1006/excr.1996.0280. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES